| [March 06, 2018] |
 |
Alnylam to Webcast Presentations at Upcoming March Investor Conferences
Alnylam
Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics
company, announced today that management will present company overviews
at the following conferences:
-
Cowen and Company 38th Annual Healthcare Conference on
Tuesday, March 13, 2018 at 12:00 pm ET at the Boston Marriott Copley
Place in Boston
-
Barclays Global Healthcare Conference on Thursday, March 15, 2018 at
2:35 pm ET at the Loews Miami Beach Hotel in Miami, Florida
A live audio webcast of each presentation will be available on the
Investors section of the Company's website, www.alnylam.com.
A replay will be available on the Alnylam website within 48 hours after
eac event.
About Alnylam Pharmaceuticals
Alnylam (Nasdaq: ALNY) is
leading the translation of RNA interference (RNAi) into a whole new
class of innovative medicines with the potential to transform the lives
of people afflicted with rare genetic, cardio-metabolic, and hepatic
infectious diseases. Based on Nobel (News - Alert) Prize-winning science, RNAi
therapeutics represent a powerful, clinically validated approach for the
treatment of a wide range of severe and debilitating diseases. Founded
in 2002, Alnylam is delivering on a bold vision to turn scientific
possibility into reality, with a robust discovery platform and deep
pipeline of investigational medicines, including four product candidates
that are in late-stage development. Looking forward, Alnylam will
continue to execute on its "Alnylam 2020" strategy of building a
multi-product, commercial-stage biopharmaceutical company with a
sustainable pipeline of RNAi-based medicines to address the needs of
patients who have limited or inadequate treatment options. Alnylam
employs over 700 people in the U.S. and Europe and is headquartered in
Cambridge, MA. For more information about our people, science and
pipeline, please visit www.alnylam.com
and engage with us on Twitter (News - Alert) at @Alnylam
or on LinkedIn.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180306006198/en/
[ Back To TMCnet.com's Homepage ]
|
